iconEarnings Announcement Before Market Open

Eiger BioPharmaceuticals Inc EIGRQ:OTCPK

*Data is delayed | Exchange | USD
Last | 3:53 PM EDT
2.25quote price arrow down-0.02 (-0.99%)
Volume
15,120
52 week range
1.10 - 43.35
Loading...
  • Open2.21
  • Day High2.25
  • Day Low2.05
  • Prev Close2.27
  • 52 Week High43.35
  • 52 Week High Date05/16/23
  • 52 Week Low1.10
  • 52 Week Low Date04/01/24

Key Stats

  • Market Cap3.332M
  • Shares Out1.48M
  • 10 Day Average Volume0.64M
  • Dividend-
  • Dividend Yield-
  • Beta2.11
  • YTD % Change-66.59

KEY STATS

  • Open2.21
  • Day High2.25
  • Day Low2.05
  • Prev Close2.27
  • 52 Week High43.35
  • 52 Week High Date05/16/23
  • 52 Week Low1.10
  • 52 Week Low Date04/01/24
  • Market Cap3.332M
  • Shares Out1.48M
  • 10 Day Average Volume0.64M
  • Dividend-
  • Dividend Yield-
  • Beta2.11
  • YTD % Change-66.59

RATIOS/PROFITABILITY

  • EPS (TTM)-50.80
  • P/E (TTM)-0.04
  • Fwd P/E (NTM)-0.14
  • EBITDA (TTM)-71.501M
  • ROE (TTM)-367.00%
  • Revenue (TTM)15.773M
  • Gross Margin (TTM)99.91%
  • Net Margin (TTM)-475.26%
  • Debt To Equity (MRQ)-284.40%

EVENTS

  • Earnings Date05/13/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Eiger BioPharmaceuticals Inc

 

Profile

MORE
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the development of therapies for hepatitis delta virus (HDV) and other serious diseases. Its HDV platform includes lonafarnib, an oral farnesylation inhibitor that targets a critical host process involved in viral replication. Its portfolio also includes avexitide, a well-characterized GLP-1 antagonist, as a targeted treatment for two metabolic diseases with high unmet medical needs. The...
Thomas Dietz Ph.D.
Independent Chairman of the Board
David Apelian M.D., Ph.D.
Chief Executive Officer, Director
Address
2155 Park Blvd
Palo Alto, CA
94306-1543
United States

Top Peers

SYMBOLLASTCHG%CHG
KPRX
Kiora Pharmaceuticals Inc
0.5097+0.0235+4.8334%
EVFM
Evofem Biosciences Inc
0.013-0.0006-4.7059%
NTII
Neurobiological Technologies Inc
0.00UNCHUNCH
SQZB
SQZ Biotechnologies Co
0.021-0.0055-20.7547%